❓Ilias Houda compares chemo-immunotherapy vs immunotherapy alone in high PD-L1 #NSCLC. Similar survival outcomes, but more toxicity with combination, raising questions about risk-benefit

#ESMO25 #MedSky #OncSky #LungCancer

Francesco Cortiula opens with a case of stage IIIB #NSCLC in a frail 76-year-old. The MDT recommends sequential chemoradiotherapy. He asks:

❓Can we de-escalate without losing radical intent?
❓Can immunotherapy reduce toxicity?
❓Can we tailor treatment to response?

#ESMO25 #MedSky #MedEd #OncSky

🌟 Discover #Avastin ( #Bevacizumab): Targeting Tumor Blood Supply!

❓ How does it block #VEGF and stop tumor growth?
⚡ Key therapy for #mCRC & #NSCLC.
💊 Trusted worldwide for cancer care.

🔗 Learn more: dengyuemed.com/product/avas...

#HongKongDrugWholesaleDistributor
#HongKongDengYueMedicine

Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted #NSCLC❓

💡Just out in @myESMO #CancerTreatmentReviews a comprehensive overview on current landscape, challenges and perspectives

Grateful to work with a global amazing team 🙏

Link to the Review:👇
doi.org/10.1016/j.ctrv…

#PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME 🔗 integrityce.com/TBT2024

🧐 Which neoadjuvant therapy would you select for stage 3B, PD-L1+ EGFR/ALK WT NSCLC ❓
A. Chemo
B. Immunotherapy
C. Chemo-immunotherapy
D. Alectinib

#PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME Eval 🔗 integrityce.com/TBTeval24
👉🏽ALL CME🔗 integrityce.com/TBT2024

🤔Which neoadj/adj sequence is likely best for a Pt with stage3B (T4N2) EGFR+ NSCLC, PD-L1=1%❓
A. Chemo-RT -> osi
B. Osi -> Adj Chemo -> osi
C. Adj Chemo-RT -> osi
D. Durva-Neoadj Chemo -> osi

#PreTest Q2⃣#TumorBoardTuesday Free #CME integrityce.com/TBT2024

🧐 Which neoadjuvant therapy would you select for stage 3B, PD-L1+ EGFR/ALK WT NSCLC ❓
A. Chemo
B. Immunotherapy
C. Chemo-immunotherapy
D. Alectinib

🤔Which neoadj/adj sequence is likely best for a patient with stage 3B (T4N2) EGFR+ NSCLC & PD-L1 of 1%❓

A. Chemo-RT -> osi
B. Osi -> Adj Chemo -> osi
C. Adj Chemo-RT -> osi
D. Durva-Neoadj Chemo -> osi

#PreTest Q1️⃣ #TumorBoardTuesday Free #CME integrityce.com/TBT2024

B4 @BalazsHalmosMD & @DAielloMD🗣️the periop mgmt of resectable #NSCLC test your🧠with this❓
👇👇🏼👇🏿